• Biocept to Host Key Opinion Leader Webinar to Discuss Its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System

    6 days ago - By San Diego Biotechnology

    SAN DIEGO--Biocept, Inc. will host a webinar featuring leading neuro-oncologists to discuss the use of the Company's proprietary cerebrospinal fluid assay for diagnosing and managing tumors that have metastasized to the central nervous system , including the brain or spinal column. Biocept's CSF assay provides enhanced...
    Read more ...